Psilocybin Blog Posts

• Psilocybin-assisted therapy for difficult-to-treat depression: underwhelming, but still vital?

  28 May 2026

  • Matt Butler

  
• In the Land of the Unblind: are psychedelics really better than antidepressants?

  27 Apr 2026

  • Luke Baxter

  
• Who gets included in psychedelics research? A systematic review of ethnoracial representation

  19 Sep 2025

  • Hári Sewell
  • and Shubhangi Karmakar

  
• Psychedelics and mental health: Can the field deliver on its promise?

  09 Jul 2025

  • Anna Zecharia

  
• Naturalistic use of psychedelics in the general population: what are the mental health risks?

  23 Jan 2025

  • Lorna Staines

  
• New and emerging treatments for major depressive disorder

  21 Aug 2024

  • Kirsten Lawson

  
• Psilocybin for ‘treatment-resistant depression’: an island of hope in an ocean of uncertainty?

  12 Jul 2023

  • UCL Psychiatry MSc

  
• Psychedelics-assisted psychotherapy for alcohol use disorder: room for more evidence

  15 May 2023

  • Heidi Stevens

  
• How could MDMA-assisted and psilocybin-assisted psychotherapy help people with depression and PTSD?

  04 Nov 2022

  • Anya Borissova
  • and Philip Brooks

  
• Turn on, or tune out? Is psilocybin assisted therapy close to becoming a first-line treatment for depression?

  03 Jul 2021

  • James Rucker
  • and Sameer Jauhar